(NCNA) – Management Comments
-
NuCana (NCNA) Reports Q1 Loss of GBP0.19
-
NuCana (NCNA) Highlights Encouraging Data for NUC-3373 in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NCNA Stock Lookup